DSM completes sale of DSM Elastomers to LANXESS
Royal DSM announced that it has completed the sale of DSM elastomers to LANXESS for € 310 million on a cash and debt-free basis. This completes the final stage of the transformation of DSM that began with the divestment program DSM announced in September 2007 as part of its Accelerated Vision 2010 program.
After all regulatory approvals were received DSM and LANXESS completed the transaction effective as per 1 May 2011. The transaction, which was announced on 14 December 2010, will result in a book profit of more than € 100 million for DSM in Q2 2011.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.